Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy
The underlying molecular mechanisms of adverse drug events (ADEs) associated with cancer therapy drugs may overlap with their antineoplastic mechanisms. In a previous study, we developed an ADE-based tumor stratification framework (known as ADEStrata) with a case study of breast cancer patients rece...
Main Authors: | Wang, Chen, Zimmermann, Michael T., Chute, Christopher G., Jiang, Guoqian |
---|---|
Format: | Online |
Language: | English |
Published: |
American Medical Informatics Association
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525249/ |
Similar Items
-
Mining severe drug-drug interaction adverse events using Semantic Web technologies: a case study
by: Jiang, Guoqian, et al.
Published: (2015) -
A Framework of Knowledge Integration and Discovery for Supporting Pharmacogenomics Target Predication of Adverse Drug Events: A Case Study of Drug-Induced Long QT Syndrome
by: Jiang, Guoqian, et al.
Published: (2013) -
ADEpedia 2.0: Integration of Normalized Adverse Drug Events (ADEs) Knowledge from the UMLS
by: Jiang, Guoqian, et al.
Published: ( 201) -
Standardizing adverse drug event reporting data
by: Wang, Liwei, et al.
Published: (2014) -
Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
by: Roitmann, Eva, et al.
Published: (2014)